Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.46
-0.33 (-3.75%)
At close: Feb 5, 2026, 4:00 PM EST
8.37
-0.09 (-1.06%)
After-hours: Feb 5, 2026, 6:07 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $444.78 million as of February 5, 2026. Its market cap has increased by 290.19% in one year.
Market Cap
444.78M
Enterprise Value
385.03M
1-Year Change
290.19%
Ranking
Category
Stock Price
$8.46
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $444.78M, an increase of 621.84%. That is a compound annual growth rate of 49.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 444.78M | 16.68% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | 61.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 424.96M |
| Benitec Biopharma | 421.92M |
| Tectonic Therapeutic | 421.49M |
| Allogene Therapeutics | 420.25M |
| Assembly Biosciences | 417.10M |
| Immutep | 415.49M |
| Anavex Life Sciences | 403.85M |
| NovaBridge Biosciences | 395.45M |